Search

Search Constraints

You searched for: Author/Creator Yuan, Yongliang

Search Results

1. A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes. (20th May 2022)

2. A tumor immune microenvironment-related integrated signature can predict the pathological response and prognosis of esophageal squamous cell carcinoma following neoadjuvant chemoradiotherapy: A multicenter study in China. (November 2022)